- Home
- IMA vs AFCG Comparison
IMA vs AFCG Comparison
Compare IMA & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMA | AFCG |
|---|---|---|
| Founded | 2019 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 61.4M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IMA | AFCG |
|---|---|---|
| Price | $5.33 | $3.44 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $16.00 | $4.50 |
| AVG Volume (30 Days) | 8.9K | ★ 95.9K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 6.94% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | $800,000.00 | ★ $24,563,601.00 |
| Revenue This Year | N/A | $1,334.03 |
| Revenue Next Year | N/A | $17.33 |
| P/E Ratio | ★ N/A | $4.79 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.94 | $2.06 |
| 52 Week High | $13.98 | $5.00 |
Technical Indicators
Market Signals| Indicator | IMA | AFCG |
|---|---|---|
| Relative Strength Index (RSI) | 40.34 | 62.87 |
| Support Level | $3.94 | $2.75 |
| Resistance Level | $6.11 | $3.50 |
| Average True Range (ATR) | 0.31 | 0.18 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 2.29 | 80.79 |
Price Performance
Historical ComparisonAbout IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
About AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.